Thomas Leissing is a highly experienced professional in the scientific and business fields, currently serving as a Transformation Manager, Creative Strategist, and Research Scientist at Evotec since March 2020. Prior to this, Thomas held the position of Postdoctoral Researcher at Bayer from October 2018 to March 2020, focusing on high-throughput crystallography, and also worked as a Postdoctoral Researcher at Oxford University from February 2018 to March 2020. Thomas holds a Doctor of Philosophy in Organic Chemistry from the University of Oxford (2014-2018) and has a Bachelor of Science in Chemistry and Biochemistry, as well as a Master of Science in Biochemistry from Ludwig-Maximilians-Universität München. Currently, Thomas is pursuing an Executive MBA at Quantic School of Business and Technology, anticipated to complete in April 2025.
This person is not in the org chart
This person is not in any teams
This person is not in any offices